AGLYCOSYLATED Fc-CONTAINING POLYPEPTIDES

Provided herein are variant human lgG1 Fe molecules lacking or with highly reduced effector function and high stability despite lacking glycosylation at N297. Also, provided herein are linker peptides that are glycosylated when expressed in mammalian cells. IL-2 binds three transmembrane receptor su...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
1. Verfasser: Gunasekaran KANNAN
Format: Patent
Sprache:eng ; spa
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Provided herein are variant human lgG1 Fe molecules lacking or with highly reduced effector function and high stability despite lacking glycosylation at N297. Also, provided herein are linker peptides that are glycosylated when expressed in mammalian cells. IL-2 binds three transmembrane receptor subunits: IL-2R- and IL-2Rywhich together activate intracellular signaling events upon IL-2 binding, and CD25 (IL-2Ra) which serves to stabilize the interaction between IL-2 and IL-2RBY.The signals delivered by IL-2RBYinclude those of the PI3-kinase, Ras-MAP-kinase, and STAT5 pathways. La presente invención se refiere a moléculas IgG1 Fc humanas variantes que carecen o con función efectora sumamente reducida y alta estabilidad a pesar de que carece de glicosilación en N297. También, se proporcionan en la presente péptidos ligadores que se glicosilan cuando se expresan en las células de mamífero.